Abstract

The COVID-19 pandemic has had a significant influence on the medical system and pharmaceutical sector in practically every nation on the planet. Communication with patients in their homes away from clinics was a typical practice in order to give safety actions to the healthcare team; however, health services have been interrupted on many levels throughout the world. The financial success of hospitals and health insurers was impacted by these measures. Another difficulty in this circumstance was the inability of medication manufacturers to get active medicinal components from Chinese companies. The considerable disruption of international trade and travel has had a negative effect on the actual economy. Different procedures based on currently available drugs were used to treat coronavirus infections.